Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (1051-1060 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|March 21, 2014
Low-dose aspirin ameliorated hyperlipidemia, adhesion molecule, and chemokine production induced by high-fat diet in Sprague-Dawley ratsHui-Li Lin, Hsueh-Wei Yen, Su-Ling Hsieh, et al.
Drug Development Research|March 21, 2014
Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE)Denong Wang, Roopa Bhat, Raymond A Sobel, et al.
Drug Development Research|October 25, 2016
Recent Developments of Hydrazide/Hydrazone Derivatives and Their Analogs as Anticonvulsant Agents in Animal ModelsViolina Angelova, Valentin Karabeliov, Pavlina A Andreeva-Gateva, et al.
Drug Development Research|October 1, 2016
Do Circadian Rhythms Draw the Patterns of Sustained Mental Vigor and Ailment?Ashish Sharma, Rohit Goyal
Drug Development Research|August 29, 2022
Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacologyMohammad Mohiminul Islam, Shama P Mirza
Drug Development Research|September 8, 2022
Nonacidic thiophene-based derivatives as potential analgesic and design, synthesis, biological evaluation, and metabolic stability studyDemiana S Mikhail, Hala B El-Nassan, Sally T Mahmoud, et al.
Drug Development Research|February 10, 2021
Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulationKarolina Pyziak, Agnieszka Sroka-Porada, Tomasz Rzymski, et al.
Drug Development Research|February 18, 2021
Design, synthesis, and biological evaluation of 3',4',5'-trimethoxy evodiamine derivatives as potential antitumor agentsYijiao Peng, Runde Xiong, Zhen Li, et al.
Drug Development Research|February 26, 2021
Irigenin alleviates angiotensin II-induced oxidative stress and apoptosis in HUVEC cells by activating Nrf2 pathwayQi Zhang, Tao Xue, Jianming Guan, et al.
Drug Development Research|July 12, 2019
Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX-G3 in healthy and neutropenia-induced ratsYun Jung Kim, Senem Ertan-Ahmed, Yilmaz Capan, et al.
Pageof 135

Showing results (1051-1060 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|March 21, 2014
Low-dose aspirin ameliorated hyperlipidemia, adhesion molecule, and chemokine production induced by high-fat diet in Sprague-Dawley ratsHui-Li Lin, Hsueh-Wei Yen, Su-Ling Hsieh, et al.
Drug Development Research|March 21, 2014
Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE)Denong Wang, Roopa Bhat, Raymond A Sobel, et al.
Drug Development Research|October 25, 2016
Recent Developments of Hydrazide/Hydrazone Derivatives and Their Analogs as Anticonvulsant Agents in Animal ModelsViolina Angelova, Valentin Karabeliov, Pavlina A Andreeva-Gateva, et al.
Drug Development Research|October 1, 2016
Do Circadian Rhythms Draw the Patterns of Sustained Mental Vigor and Ailment?Ashish Sharma, Rohit Goyal
Drug Development Research|August 29, 2022
Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacologyMohammad Mohiminul Islam, Shama P Mirza
Drug Development Research|September 8, 2022
Nonacidic thiophene-based derivatives as potential analgesic and design, synthesis, biological evaluation, and metabolic stability studyDemiana S Mikhail, Hala B El-Nassan, Sally T Mahmoud, et al.
Drug Development Research|February 10, 2021
Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulationKarolina Pyziak, Agnieszka Sroka-Porada, Tomasz Rzymski, et al.
Drug Development Research|February 18, 2021
Design, synthesis, and biological evaluation of 3',4',5'-trimethoxy evodiamine derivatives as potential antitumor agentsYijiao Peng, Runde Xiong, Zhen Li, et al.
Drug Development Research|February 26, 2021
Irigenin alleviates angiotensin II-induced oxidative stress and apoptosis in HUVEC cells by activating Nrf2 pathwayQi Zhang, Tao Xue, Jianming Guan, et al.
Drug Development Research|July 12, 2019
Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX-G3 in healthy and neutropenia-induced ratsYun Jung Kim, Senem Ertan-Ahmed, Yilmaz Capan, et al.
Pageof 135